Si prevede che il mercato globale della diagnostica della sepsi crescerà a un CAGR dell'8,85% dal 2022 al 2029. Si prevede che raggiungerà oltre 979,13 milioni di USD entro il 2029 dai 469,22 milioni di USD nel 2020.
La sepsi è una malattia potenzialmente letale che si verifica quando il sistema immunitario del corpo distrugge i propri tessuti in risposta a un'infezione. Quando i sistemi di lotta contro le infezioni del corpo si attivano, gli organi funzionano male e in modo inappropriato. La sepsi può portare allo shock settico. Si tratta di un brusco calo della pressione sanguigna che può causare gravi danni agli organi e persino la morte. Il trattamento con antibiotici e fluidi endovenosi il prima possibile migliora le possibilità di sopravvivenza.
Inoltre, l'espansione dei finanziamenti pubblico-privati per le attività di ricerca diagnostica sulla sepsi, il crescente peso delle malattie infettive, il crescente numero di casi di sepsi e i crescenti programmi governativi per aumentare la consapevolezza sulla sepsi sono tutti fattori che probabilmente stimoleranno la domanda di dispositivi diagnostici per la sepsi. Si prevede che il mercato per la diagnostica della sepsi si svilupperà in modo significativo durante il periodo di previsione, a causa di un aumento del peso della sepsi e di un aumento della popolazione geriatrica mondiale. I principali fattori trainanti della crescita del mercato includono un aumento dei finanziamenti governativi per gli sforzi di ricerca correlati alla sepsi, nonché un aumento della prevalenza di malattie infettive. D'altro canto, si prevede che lo sviluppo di approcci di diagnosi rapida/point-of-care per diagnosi precoci di sepsi creerà opportunità redditizie per i principali partecipanti del settore durante tutto il periodo di proiezione.
ATTRIBUTO | DETTAGLI |
Periodo di studio | 2020-2029 |
Anno base | 2021 |
Anno stimato | 2022 |
Anno previsto | 2022-2029 |
Periodo storico | 2018-2020 |
Unità | Valore (milioni di USD) |
Segmentazione | Per prodotto, per metodo, per tipo di test, per agente patogeno, per tecnologia, per utente finale, per regione |
Per Prodotto |
|
Per metodo |
|
Per tipo di test |
|
Per agente patogeno |
|
Per tecnologia |
|
Per utente finale |
|
Per regione |
|
Tuttavia, l'elevato costo degli strumenti diagnostici automatizzati limita l'espansione del mercato. La sepsi è una malattia potenzialmente fatale che deve essere rilevata e curata il prima possibile da esperti sanitari qualificati. In tutto il mondo, c'è una carenza cronica di esperti competenti; solo la metà dei pazienti con sepsi grave trasportati dal sistema EMS ha un paramedico. La carenza di paramedici qualificati ha un impatto su tutte le fasi dell'assistenza ai pazienti, tra cui la consapevolezza della sepsi, la valutazione dei pazienti per la presenza di sepsi e l'adozione di decisioni terapeutiche appropriate.
La pandemia di COVID-19 si è diffusa in tutto il mondo e ha interrotto la catena di fornitura a livello globale. A causa del lockdown, il processo di produzione di tutti i settori è stato interrotto, chiuso o deviato verso la guarigione dei pazienti covid e ciò ha comportato una diminuzione della domanda di diagnostica della sepsi sul mercato. Il settore delle telecamere mediche ha sofferto a causa dei ritardi nelle procedure mediche e negli interventi chirurgici. Con l'apertura dei mercati mondiali, si stanno concentrando sull'avere più telecamere per la supervisione e si prevede che otterranno una potenziale crescita nel mercato della diagnostica della sepsi.
The Sepsis Diagnostics market size had crossed USD 32.50 million in 2020 and will observe a CAGR of more than 8.85% up to 2029 driven by the rise in sepsis diseases and diagnostic surgeries in healthcare industry.
North America accounted for a 42% share of the sepsis diagnostics market in 2020 and is expected to maintain its dominance during the forecast period.
Rising number of sepsis occurrences, and growing government programmes to raise sepsis awareness are all likely to drive demand for sepsis diagnostic devices and thus market growth. Development of quick diagnosis/point-of-care approaches for early sepsis diagnoses is expected to create lucrative opportunities to major industry participants. But the high cost of automated diagnostics instruments limits the market expansion.
bioMérieux, Becton, Dickinson and Company, Danaher Corporation, T2 Biosystems, Luminex, Roche Diagnostics, Thermo Fisher Scientific, Bruker Corporation, Abbott Laboratories, Immunexpress, Axis-Shield Diagnostics, Quidel Corporation, and others., are among the leading players in the global sepsis diagnostics market.
Presence of a highly developed healthcare system, high adoption of innovative sepsis diagnostic technologies among medical professionals, a rising number of surgical procedures, in the North American region, it accounted for a large share of sepsis diagnostics market in 2020 and is expected to maintain its dominance during the forecast period.
Due to its large patient population, increasing sepsis diagnostics usage in healthcare industry, as well as the rise in geriatric population, Asia-Pacific is expected to have the highest CAGR in coming years.
The global sepsis diagnostics market is segmented by product, method, test type, pathogen, technology, end user and region.
Based on product segment, the sepsis diagnostics market includes Blood Culture Media, Reagents, Assay, Instruments, Software. During the projection period, the blood culture media segment had the greatest market share. This proportion may be ascribed to the increasing use of blood culture media for the diagnosis of sepsis by hospitals and pathology labs, as well as an increase in the market availability of blood culture media.
The sepsis diagnostics market can be classified based on the method, that is Automated Diagnostics, Conventional Diagnostics. Due to the greater cost of automated diagnostics equipment, the traditional diagnostics segment currently leads the market and is likely to stay dominant over the forecast period.
Based on test type segment, the sepsis diagnostics market includes Lab, POC. The laboratory testing segment now leads the market and is projected to do so for the foreseeable future. This is due to the fact that lab testing is more accurate than point-of-care testing for detecting sepsis. Furthermore, the increased dependence of patients and clinicians on laboratory testing drives the growth of the sepsis diagnostic market.
The sepsis diagnostics market can be classified based on the pathogen, that is Bacterial, Viral, Fungal. The bacterial sepsis category held the greatest market share. This increase can be ascribed to an increase in bacterial sepsis cases, an increase in surgical operations, and an increase in the prevalence of HAIs.
Based on technology segment, the sepsis diagnostics market includes Blood Culture, Microbiology, PCR, Sequencing, Biomarkers, Microfluidics, Immunoassays. The blood culture segment held the greatest market share. This proportion can be ascribed to the inexpensive cost of microbiology techniques as well as the widespread usage of blood culture methods for sepsis diagnosis.
Based on end-user segment, the sepsis diagnostics market includes Hospital, Pathology Lab, Research Laboratories & Academic Institutes. The hospitals and specialty clinics have the biggest share of the sepsis diagnostics market. The larger share of this segment can be attributed to the high prevalence of sepsis, as well as the large number of fatalities caused by the illness, the increasing number of patients hospitalized with sepsis, and in-house hospital laboratories performing a large number of blood culture tests to identify blood stream infections (BSIs caused by bacteria, fungi/yeast, or viruses).
[caption id="attachment_10025" align="alignleft" width="680"]The global sepsis diagnostics market key players include bioMérieux, Becton, Dickinson and Company, Danaher Corporation, T2 Biosystems, Luminex, Roche Diagnostics, Thermo Fisher Scientific, Bruker Corporation, Abbott Laboratories, Immunexpress, Axis-Shield Diagnostics, Quidel Corporation, and others.
Various businesses are focusing on organic growth tactics such as new launches, product approvals, and other things like patents and events. Mergers & Acquisitions, partnerships, and collaborations were among the inorganic growth tactics observed in the market. These initiatives such as developing new products and upgrading others, have paved the road for market participants to expand their business. These market players in the sepsis diagnostics market are expected to benefit from attractive growth prospects in the future.
April 12th 2022-bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire Specific Diagnostics, a privately held U.S. based company that has developed a rapid antimicrobial susceptibility test (AST) system that delivers phenotypic AST directly from positive blood cultures.The sepsis diagnostics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
North America has a dominating share in the global sepsis diagnostics market due to well established healthcare industry, rising prevalence of sepsis diseases and diagnostic procedures. Followed by Asia Pacific & Europe, owing to rise in technology advancements, as well as investments by government in funding the healthcare industry and devices.
[caption id="attachment_10026" align="alignleft" width="680"]Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.